| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785877 | Cancer Treatment Reviews | 2018 | 8 Pages |
Abstract
Sarcomas are rare cancers whose molecular pathogenesis is becoming increasingly understood. The current evidence demonstrates that molecular analyses are useful in the diagnosis and prediction of prognosis in some STS.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Rita A. Kandel, Xiaomei Yao, Brendan C. Dickson, Michelle Ghert, Snezana Popovic, Bibianna M. Purgina, Shailendra Verma, Joel Werier,